Skip to content
Aperlena
Free alerts

Tender notices: Germany, July 2025

July 2025, Germany: 65 notices, each with a page of its own here. This page lists 65 of them: 6 Jul 2025 to 27 Jul 2025. They come from 17 contracting authorities. The sector with the most of them here: Medical equipment & pharmaceuticals.

Statistics: July 2025 All months: Germany Search tenders: Germany

Published Notice Buyer est. value
6 Jul Medicines - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V via an open-house model for the active ingredient alitretinoin (WHO ATC code: D11AH04) AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
7 Jul Medicines - Conclusion of a non-exclusive discount agreement under Section 130a (8) SGB V for medicines with the active ingredient Nilotinib (ATC code L01EA03) AOK Niedersachsen. Die Gesundheitskasse.
7 Jul Medicines - Conclusion of non-exclusive rebate agreements under Sec. 130a para. 8 SGB V for the listed active substances with the option to join via an open-house procedure KKH Kaufmännische Krankenkasse
7 Jul Medicines - Conclusion of non-exclusive discount agreements under Section 130a (8) SGB V for medicines with the active ingredient Naloxegol (ATC code A06AH03) AOK Niedersachsen. Die Gesundheitskasse.
7 Jul Architectural, engineering and testing services - Conclusion of a non-exclusive framework contract for checking engineer services 2025 ff. via Open House procedure of Autobahn GmbH (OH-ZEN-2025_02) Die Autobahn GmbH des Bundes
8 Jul Medicines - Conclusion of non-exclusive discount agreements under Section 130a (8) SGB V via an open-house model for the active ingredient Naproxen/Esomeprazol (WHO ATC code: M01AE52) AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
8 Jul Medicines - Non-exclusive rebate contracts under § 130a para. 8 SGB V for medicinal products with the active ingredient combination naproxen and esomeprazole (ATC code: M01AE52) AOK Niedersachsen. Die Gesundheitskasse.
8 Jul Pharmaceuticals - Non-exclusive rebate contract under Section 130a(8) SGB V for medicinal products with the active ingredient colistin (ATC code J01XB01) AOK Niedersachsen. Die Gesundheitskasse.
10 Jul Medicines - Conclusion of non-exclusive rebate agreements under § 130a para. 8 SGB V (Open House model) AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 61964069711 Fax: +49 6966816559711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/
10 Jul Medicines - Open house discount agreements for blood glucose test strips AOK Bayern - Die Gesundheitskasse
10 Jul Medicines - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V for the active substance methylphenidate in tablet form GWQ ServicePlus AG
10 Jul Medical aids - Open framework agreement on discounts under Section 130a paragraph 8 SGB V with the option to join at any time, so-called approval model, for blood glucose test strips for the federal state of North Rhine-Westphalia Deutsche Rentenversicherung Knappschaft-Bahn-See
10 Jul Medicines - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V for the listed active substances, with the option to join via the so-called Open House procedure. KKH Kaufmännische Krankenkasse
10 Jul Asbestos removal works - Asbestos exposure during work on plasters, fillers and tile adhesives - Framework agreement with specialist remediation contractors (Open-House procedure) Kooperation der BGETEM, BGBau, BGHM durchgeführt durch BGHM
13 Jul Medicines - Medicines containing the active substances tramadol and paracetamol (ATC: N02AJ13) AOK Sachsen - Anhalt
13 Jul Medicines - Open house discount contracts Pyridostigmin, ATC N07AA02 AOK Bayern - Die Gesundheitskasse
13 Jul Medicines - Medicines with the finished medicinal product Oralair (ATC: V01AA02 - grass pollen) AOK Sachsen - Anhalt
13 Jul Medicines - Open house discount agreements for aripiprazole depot injection suspension, ATC N05AX12 AOK Bayern - Die Gesundheitskasse
13 Jul Medicines - Open house rebate agreements for the active ingredient Fluorouracil, ATC D11AF05 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
13 Jul Medicines - Open house rebate agreements on amifampridine, ATC N07XX05 AOK Bayern - Die Gesundheitskasse
13 Jul Medicines - Open house discount agreements for the active substances Lamivudine, Abacavir and Dolutegravir, ATC J05AR13 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
13 Jul Medicinal products - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V for the named active substances, with the option to join via the Open House procedure KKH Kaufmännische Krankenkasse
13 Jul Medicines - Medicines containing the active substance Tolvaptan (ATC: G04BX21 - excluding medicines with uniform strengths) AOK Sachsen - Anhalt
13 Jul Medicinal products - Medicinal products with the active ingredient fusidic acid (ATC: D06AX01) AOK Sachsen - Anhalt
13 Jul Medicines - Open-House Biosimilar Rebate Contracts 2025-21 - Teriparatide Techniker Krankenkasse; HEK - Hanseatische Krankenkasse; Handelskrankenkasse (hkk)
13 Jul Pharmaceuticals - Open house rebate contracts for the active substance Inclisiran, ATC C10AX16 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
13 Jul Medicines - Open house model discount agreements for rivaroxaban film-coated tablets, excluding the 2.5 mg strength, ATC B01AF01 AOK Bayern - Die Gesundheitskasse
13 Jul Medicines - Open house rebate agreements for erythropoietin alfa, ATC B03XA01 AOK Bayern - Die Gesundheitskasse
13 Jul Medicines - Open house rebate agreements for the active substance Roxadustat, ATC B03XA05 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
13 Jul Medicines - Open house rebate agreements for adalimumab, ATC L04AB04 AOK Bayern - Die Gesundheitskasse
13 Jul Medicines - Open house rebate contracts for the active substances lamivudine and dolutegravir, ATC J05AR25 AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
14 Jul Medicinal products - Conclusion of non-exclusive rebate agreements for medicinal products under Section 130a (8) SGB V via an open-house model for the active substance Diclofenac (ATC code according to WHO: D11AX18) AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
15 Jul Medicines - Conclusion of non-exclusive rebate agreements for medicines under Section 130a (8) SGB V via an Open-House model for the active substance Amifampridine (ATC code: N07XX05) AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
15 Jul Medicines - Conclusion of non-exclusive rebate agreements for medicines under Section 130a (8) SGB V via an open-house model for the active ingredient rasagiline (ATC code: N04BD02) AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
15 Jul Medicines - Conclusion of a non-exclusive rebate contract under § 130a para. 8 SGB V for medicines with the active ingredient Relugolix (ATC code: L02BX04) AOK Niedersachsen. Die Gesundheitskasse.
15 Jul Medicines - Conclusion of non-exclusive rebate agreements under Section 130a (8) SGB V for the named active substances with the option to join within the so-called Open House procedure KKH Kaufmännische Krankenkasse
16 Jul Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a(8) SGB V for the active substance Umeclidinium, ATC R03BB07, for the period 01.09.2025 to 31.08.2027 DAK-Gesundheit
16 Jul Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a Para. 8 SGB V for the active substance Abrocitinib, ATC D11AH08, for the period 01.09.2025 - 31.08.2027 DAK-Gesundheit
16 Jul Medical devices - Open framework agreement on rebates under Section 130a(8) SGB V with open accession, the admission model, for blood glucose test strips in North Rhine-Westphalia Deutsche Rentenversicherung Knappschaft-Bahn-See
16 Jul Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a(8) SGB V for the active ingredient Ruxolitinib, ATC D11AH09, for the period 01.09.2025 - 31.08.2027 DAK-Gesundheit
16 Jul Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a(8) SGB V for the active ingredient Glecaprevir and Pibrentasvir, ATC J05AP57, for the period 01.09.2025 to 31.08.2027 DAK-Gesundheit
16 Jul Medicines - Conclusion of a non-exclusive rebate agreement under § 130a (8) SGB V for the active substance Axitinib, ATC L01EK01 for the period 01.09.2025 - 31.08.2027 (plus extension option 1x12 months) DAK-Gesundheit
16 Jul Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a(8) SGB V for the active substance Tofacitinib, ATC L04AF01, for the period 01.09.2025 - 31.08.2027 (plus extension option 1x12 months) DAK-Gesundheit
16 Jul Medicines - Non-exclusive rebate agreement under § 130a para. 8 SGB V for the active ingredient Naproxen + Esomeprazol, ATC M01AE52, from 01.09.2025 to 31.08.2027 (plus extension option 1x12 months) DAK-Gesundheit
16 Jul Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a (8) SGB V for the active ingredient Tafluprost + Timolol, ATC S01ED70, for the period 01.09.2025 - 31.08.2027 DAK-Gesundheit
16 Jul Medicines - Conclusion of a non-exclusive discount agreement under Section 130a(8) SGB V for the active substance Amifampridine, ATC N07XX05, from 01.09.2025 to 31.08.2027 (plus extension option 1x12 months) DAK-Gesundheit
16 Jul Medicinal products - Open-House biosimilar discount agreements 2025-20 - Pegfilgrastim Techniker Krankenkasse; HEK - Hanseatische Krankenkasse; Handelskrankenkasse (hkk)
16 Jul Medicines - Conclusion of a non-exclusive rebate agreement under Section 130a(8) SGB V for the active substance Eltrombopag, ATC B02BX05, from 01.09.2025 to 31.08.2027 (plus one 12-month extension option) DAK-Gesundheit
16 Jul Drug rebate agreements under § 130a(8) SGB V via Open House procedures IKK classic
17 Jul Bridge inspections - Conclusion of a non-exclusive framework agreement for structural inspections according to DIN 1076, Open House procedure, Western branch, published 2023 Autobahn GmbH des Bundes - NL West
17 Jul Medicines - Rebate contracts for medicinal products from 01.09.2025 for various active substances under an open-house procedure AOK NordWest
20 Jul Medicines - Open-house rebate contracts 2025-08 Techniker Krankenkasse; HEK - Hanseatische Krankenkasse; Handelskrankenkasse (hkk)
20 Jul Medicines - Conclusion of non-exclusive rebate agreements under Section 130a Paragraph 8 SGB V for the stated active substances, with the option to join under the so-called open-house procedure KKH Kaufmännische Krankenkasse
20 Jul Medicines - Open-house discount agreements 2025-06 Techniker Krankenkasse; Handelskrankenkasse (hkk); HEK - Hanseatische Krankenkasse
20 Jul Medicines - Conclusion of non-exclusive rebate agreements under Section 130a Paragraph 8 SGB V for the named active substances, joinable via an Open House procedure. KKH Kaufmännische Krankenkasse
20 Jul Medicines - Non-exclusive rebate contract under Section 130a(8) SGB V for medicines with the active ingredient Omalizumab (ATC code R03DX05) AOK Niedersachsen. Die Gesundheitskasse.
20 Jul Medicines - Open framework agreement on medicine discounts under Section 130a(8) SGB V with open accession at any time, so-called approval model 2025-07 Deutsche Rentenversicherung Knappschaft-Bahn-See
20 Jul Medicines - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V for the named active substances, with the option to join under an open-house procedure KKH Kaufmännische Krankenkasse
22 Jul Medicines - Open House Original Rebate Contracts 2025-21 - Sofosbuvir, Velpatasvir, Voxilaprevir (active ingredient combination) Techniker Krankenkasse; HEK - Hanseatische Krankenkasse; Handelskrankenkasse (hkk)
22 Jul Medicines - Open House Original Discount Agreements 2025-23 - Rilpivirin (film-coated tablets) Techniker Krankenkasse; HEK - Hanseatische Krankenkasse; Handelskrankenkasse (hkk)
24 Jul Medicines - Open-house rebate agreements for aripiprazole in depot injection suspension form, ATC N05AX12 (copy) AOK Bayern - Die Gesundheitskasse
24 Jul Medicines - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V for the named active substances via an Open House procedure KKH Kaufmännische Krankenkasse
27 Jul Medicines - Conclusion of non-exclusive rebate agreements under § 130a para. 8 SGB V for the named active substances with the option to join via an Open House procedure KKH Kaufmännische Krankenkasse
27 Jul Medicines - Open-house rebate agreements 2025-09 Techniker Krankenkasse; HEK - Hanseatische Krankenkasse; Handelskrankenkasse (hkk)
27 Jul Medicines - Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V for the named active substances, accessible via an open-house procedure KKH Kaufmännische Krankenkasse

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language